168 related articles for article (PubMed ID: 11214930)
1. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro.
Post K; Brown DR; Groschup M; Kretzschmar HA; Riesner D
Arch Virol Suppl; 2000; (16):265-73. PubMed ID: 11214930
[TBL] [Abstract][Full Text] [Related]
2. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
3. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions between prions as seeds and recombinant prion proteins as substrates resemble the biological interspecies barrier in vitro.
Panza G; Luers L; Stöhr J; Nagel-Steger L; Weiss J; Riesner D; Willbold D; Birkmann E
PLoS One; 2010 Dec; 5(12):e14283. PubMed ID: 21151607
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
[TBL] [Abstract][Full Text] [Related]
7. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity.
Shaked GM; Fridlander G; Meiner Z; Taraboulos A; Gabizon R
J Biol Chem; 1999 Jun; 274(25):17981-6. PubMed ID: 10364247
[TBL] [Abstract][Full Text] [Related]
8. X-ray diffraction of scrapie prion rods and PrP peptides.
Nguyen JT; Inouye H; Baldwin MA; Fletterick RJ; Cohen FE; Prusiner SB; Kirschner DA
J Mol Biol; 1995 Sep; 252(4):412-22. PubMed ID: 7563061
[TBL] [Abstract][Full Text] [Related]
9. Separation of scrapie prion infectivity from PrP amyloid polymers.
Wille H; Zhang GF; Baldwin MA; Cohen FE; Prusiner SB
J Mol Biol; 1996 Jun; 259(4):608-21. PubMed ID: 8683568
[TBL] [Abstract][Full Text] [Related]
10. Is the prion structure solved?
Liberski PP; Bratosiewicz-Zapart J
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):121-40. PubMed ID: 9597078
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
12. Disruption of prion rods generates 10-nm spherical particles having high alpha-helical content and lacking scrapie infectivity.
Riesner D; Kellings K; Post K; Wille H; Serban H; Groth D; Baldwin MA; Prusiner SB
J Virol; 1996 Mar; 70(3):1714-22. PubMed ID: 8627692
[TBL] [Abstract][Full Text] [Related]
13. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
14. Synthetic scrapie infectivity: interaction between recombinant PrP and scrapie brain-derived RNA.
Simoneau S; Thomzig A; Ruchoux MM; Vignier N; Daus ML; Poleggi A; Lebon P; Freire S; Durand V; Graziano S; Galeno R; Cardone F; Comoy E; Pocchiari M; Beekes M; Deslys JP; Fournier JG
Virulence; 2015; 6(2):132-44. PubMed ID: 25585171
[TBL] [Abstract][Full Text] [Related]
15. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
16. Tetracyclines affect prion infectivity.
Forloni G; Iussich S; Awan T; Colombo L; Angeretti N; Girola L; Bertani I; Poli G; Caramelli M; Grazia Bruzzone M; Farina L; Limido L; Rossi G; Giaccone G; Ironside JW; Bugiani O; Salmona M; Tagliavini F
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10849-54. PubMed ID: 12149459
[TBL] [Abstract][Full Text] [Related]
17. Creutzfeldt-Jakob disease and scrapie prions.
Prusiner SB
Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
[TBL] [Abstract][Full Text] [Related]
18. Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen.
Panza G; Stöhr J; Birkmann E; Riesner D; Willbold D; Baba O; Terashima T; Dumpitak C
Rejuvenation Res; 2008 Apr; 11(2):365-9. PubMed ID: 18341429
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro neurotoxicity of the human prion protein (PrP) fragment P118-135 independently of PrP expression.
Chabry J; Ratsimanohatra C; Sponne I; Elena PP; Vincent JP; Pillot T
J Neurosci; 2003 Jan; 23(2):462-9. PubMed ID: 12533606
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology and transgenetics of prion diseases.
Prusiner SB
Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
